Back to top
more

Chemours (CC)

(Real Time Quote from BATS)

$12.04 USD

12.04
1,035,050

+0.04 (0.33%)

Updated Aug 7, 2025 11:36 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 6% (231 out of 246)

Industry: Chemical - Diversified

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Sherwin-Williams (SHW) Earnings & Sales Beat Estimates in Q3

by Zacks Equity Research

Sherwin-Williams' (SHW) Q3 results benefit from strong demand in its pro-architectural and industrial end markets amid headwinds from raw material supply chain challenges.

Zacks Equity Research

Eastman Chemical (EMN) to Post Q3 Earnings: What's in Store?

by Zacks Equity Research

Eastman Chemical's (EMN) Q3 performance is likely to have benefited from cost-management actions and new business revenues from innovation.

Zacks Equity Research

Newmont (NEM) to Post Q3 Earnings: What's in the Cards?

by Zacks Equity Research

Newmon''s (NEM) results in the third quarter are likely to reflect the weakness in gold prices.

Zacks Equity Research

Chemours (CC) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Chemours (CC) closed the most recent trading day at $29.43, moving +0.82% from the previous trading session.

Zacks Equity Research

Are Investors Undervaluing Chemours (CC) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Methanex (MEOH) to Post Q3 Earnings: What's in the Cards?

by Zacks Equity Research

Methanex's (MEOH) third-quarter performance is likely to reflect healthy methanol demand and improvement in pricing.

Zacks Equity Research

Can Linde (LIN) Keep the Earnings Surprise Streak Alive in Q3?

by Zacks Equity Research

Higher industrial gas sales are likely to have aided Linde???s (LIN) Q3 earnings.

Zacks Equity Research

U.S. Steel (X) to Post Q3 Earnings: What's in the Cards?

by Zacks Equity Research

U.S. Steel's (X) Q3 results are likely to have benefited from strong demand across end markets and higher domestic steel prices.

Zacks Equity Research

Sherwin-Williams (SHW) to Post Q3 Earnings: What's in Store?

by Zacks Equity Research

Sherwin-Williams' (SHW) third-quarter performance is likely to reflect strong demand and cost-control initiatives.

Anindya Barman headshot

4 Chemical Stocks Set to Pull Off a Beat This Earnings Season

by Anindya Barman

Strong end-market demand and benefits of self-help actions are likely to reflect on the Q3 performance of Westlake (WLK), Tronox (TROX) and Chemours (CC) and Albemarle (ALB).

Zacks Equity Research

Freeport's (FCX) Q3 Earnings Top, Revenues Lag Estimates

by Zacks Equity Research

Freeport's (FCX) Q3 earnings gain from higher realized prices and lower costs.

Zacks Equity Research

PPG Industries (PPG) Tops Q3 Earnings and Revenue Estimates

by Zacks Equity Research

PPG Industries (PPG) Q3 results are driven by higher selling prices, offset by raw material cost inflation and lower sales volumes.

Zacks Equity Research

Barrick (GOLD) Q3 Production Rises, Set to Achieve FY21 Targets

by Zacks Equity Research

Barrick (GOLD) reports preliminary third-quarter sales of 1.07 million ounces of gold as well as preliminary production of 1.09 million ounces.

Zacks Equity Research

Cleveland-Cliffs (CLF) to Report Q3 Earnings: What's in Store?

by Zacks Equity Research

Cleveland-Cliffs (CLF) is expected to have benefited from higher steel demand and prices and contributions from acquisitions in Q3.

Zacks Equity Research

Will Higher Selling Prices Drive Nucor's (NUE) Q3 Earnings?

by Zacks Equity Research

Profitability across Nucor's (NUE) steel mills and steel products segments is expected to have boosted by higher average sales prices in Q3.

Zacks Equity Research

Olin (OLN) to Report Q3 Earnings: What's in the Offing?

by Zacks Equity Research

Olin's (OLN) Q3 performance is likely to have benefited from productivity actions and strong performance in the Winchester business.

Zacks Equity Research

Will Chemours (CC) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

Chemours (CC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

Chemours (CC) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Chemours (CC) closed the most recent trading day at $30.64, moving -0.81% from the previous trading session.

Zacks Equity Research

Chemours (CC) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

Chemours (CC) closed at $30.91 in the latest trading session, marking a -1.47% move from the prior day.

Zacks Equity Research

Is The Chemours (CC) Stock Outpacing Its Basic Materials Peers This Year?

by Zacks Equity Research

Is (CC) Outperforming Other Basic Materials Stocks This Year?

Zacks Equity Research

Axalta (AXTA) Launches Imron HPU DTM Primer, Boosts Portfolio

by Zacks Equity Research

Axalta's (AXTA) Imron Industrial HPU DTM primer showcases the added value and diversification of its Imron Industrial portfolio.

Zacks Equity Research

UAW Employees Ratify Cleveland-Cliffs' (CLF) New Labor Deal

by Zacks Equity Research

Cleveland-Cliffs' (CLF) agreement with UAW enables it to maintain its competitive cost structure in flat-rolled steel compared with any of its peers.

Zacks Equity Research

GrowGeneration (GRWG) Inks Distribution Agreement for DYNOMYCO

by Zacks Equity Research

GrowGeneration (GRWG) agreement with Groundwork BioAg will enable it to offer the latter???s mycorrhizal inoculant DYNOMYCO, which has exhibited strong efficacy in cannabis.

Zacks Equity Research

Should Value Investors Buy Chemours (CC) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Vale (VALE) Suspends Copper Concentrate Production at Salobo

by Zacks Equity Research

Due to fire affecting a conveyor belt, Vale S.A (VALE) halts copper concentrate production at Salobo. It is expected to resume by the end of this month.